Kaposi's sarcoma, and the specimen was sent for a routine mycobacterial culture. A diagnosis of disseminated tuberculosis was made on the basis of the patient's clinical presentation and the
Cutaneous Miliary Tuberculosis in a Patient Infected
presence of adenopathy; he was discharged and received antituberwith Human Immunodeficiency Virus culous therapy as an outpatient. Mycobacterium tuberculosis was cultured from the skin biopsy specimen 2 weeks later.
While cutaneous manifestations are common in the HIV-positive SIR-Libraty and Byrd [1] recently described a case of cutaneous miliary tuberculosis in an HIV-positive patient and reviewed the population in Cape Town, South Africa, few lesions are biopsied, so we may have missed other cases of cutaneous miliary tuberculopublished cases of cutaneous miliary tuberculosis among patients with AIDS [1] . The authors claimed that only six cases (including sis. However, as was true for our patient, the diagnosis of disseminated tuberculosis is usually evident on clinical grounds; cultures are their own case) have been reported so far. However, they did not mention two cases of cutaneous miliary tuberculosis due to performed to confirm the diagnosis and to exclude drug resistance. Although the positive culture of the skin biopsy specimen conmultidrug-resistant Mycobacterium tuberculosis in patients with AIDS, which we described previously [2] . Since the publication firmed the diagnosis for our patient, the result was unexpected; if the result had been negative, treatment would have been continued. of our report in October 1995, we have diagnosed a further case of cutaneous miliary tuberculosis, also known as tuberculosis cutis Similarly, in the case reported by Libraty and Byrd, the patient's risk factors and presentation, apart from the short history of sympmiliaris disseminata (TCMD).
A 38-year-old man with an 8-year history of intravenous drug toms, were suggestive of disseminated tuberculosis. Further, the positive culture result for the skin biopsy specimen became availabuse who was receiving methadone maintenance therapy presented with a 1-week history of high fever (temperature, 40ЊC), able after acid-fast bacilli had been seen on examination of bronchoalveolar lavage fluid and bone marrow biopsy specimens. chills, a nonproductive cough, epigastric pain, and dysphagia. He had been aware of his HIV seropositivity for 3 months. He was In conclusion, our own experience and that of other investigators [2] is that an HIV-related diagnosis of extrapulmonary tuberculosis not receiving any antiretroviral therapy or prophylaxis for Pneumocystis carinii pneumonia. can usually be made without performing a skin biopsy. Notwith-dence of this form of tuberculosis seems to be increasing. Therefore, when multiple papulovesicular skin lesions are present in a severely ill patient, this condition should be clinically suspected. We agree with Libraty and Byrd that the absence of a miliary pattern on a chest radiograph should not lead to exclusion of the diagnosis of TCMD, since none of our three patients presented with this radiographic picture. The finding of typical choroidal tubercles on ophthalmologic examination could be helpful in supporting the diagnosis of TCMD before the results of histological and microbiological examination of a skin biopsy specimen are available. and splenomegaly with multiple pinpoint hyperechogenic lesions. Esophagogastroduodenoscopy revealed a large ulcer (5 1 6 cm) without protruding edges in the last portion of the esophagus. Multiple Reply blood cultures were performed.
On the second hospital day, the patient developed a diffuse maculopapular skin eruption (figure 1) involving the trunk, abdo-SIR-Antinori et al. [1] note that they have reported two cases of cutaneous miliary tuberculosis in patients with AIDS that were men, arms, and legs. He complained of myalgias and severe dysphagia and was confused. A serum cryptococcal antigen test was not included in our review [2] . Furthermore, they present another case that adds to the growing literature on tuberculosis cutis milinegative. A skin biopsy was performed, and because of the similarity between the cutaneous lesions and those in the cases of TCMD aris disseminata in patients with AIDS. We apologize for our oversight and concur with their observations and conclusions. that we had already seen, we decided to start antituberculous therapy (iv rifampin, isoniazid, and ethambutol at standard doses) plus Hudson et al. point out that they have observed only one case of cutaneous tuberculosis in almost 400 HIV-seropositive patients iv therapy with amikacin (1 g/d). An ophthalmologic evaluation showed yellow choroidal lesions in the right eye that were also with tuberculosis. The rarity of cutaneous miliary tuberculosis in HIV-seronegative adults has been well established over the past compatible with a diagnosis of miliary tuberculosis. Five days later, histological examination of the skin biopsy specimen showed century. Although cutaneous miliary tuberculosis is obviously not a common entity, its prevalence among HIV-seropositive patients focal areas of necrosis containing multiple acid-fast bacilli. M. tuberculosis subsequently grew from cultures of blood and would appear to be higher than among HIV-seronegative patients, as evidenced by the continuing case reports submitted by us [2] , cultures of the skin biopsy specimen. The isolated strain was resistant to isoniazid.
Franca et al. [3] , Oliva et al. [4] , and Antinori et al. [1] . Even a prevalence of 0.5% among HIV-seropositive individuals with The clinical condition of the patient rapidly improved. His fever disappeared 5 days after the antituberculous therapy was begun, tuberculosis would bear out this statement. As mentioned in our article, the occurrence of disseminated cutaneous tuberculosis, like and liver-function test results returned to normal 7 days later. The cutaneous lesions completely disappeared 2 weeks later, and an other extrapulmonary manifestations of tuberculosis, simply reflects the stage of HIV disease and consequent cell-mediated imabdominal ultrasonogram obtained 5 weeks after the first one was obtained showed nearly complete regression of the lesions. The mune defects. We agree that biopsy of cutaneous lesions is not generally the patient was discharged in good health 6 weeks after admission.
Cutaneous miliary tuberculosis is still an uncommon disease, crux of the diagnosis of disseminated tuberculosis in HIV-seropositive patients; when disseminated tuberculosis is suspected, empirieven in the setting of HIV infection, but in recent years the inci-cal therapy may be warranted. However, even when tuberculosis A 20-month-old male underwent removal of a ventriculoperitoneal (VP) shunt because of presumed infection. Cultures of CSF is suspected, a primary goal should be to obtain adequate clinical specimens for culture and susceptibility testing of Mycobacterium and cultures of the shunt itself were sterile, and a new shunt was inserted after 5 days. After insertion of the shunt, the infant was tuberculosis isolates. This is especially true in the HIV era, given the ability of M. tuberculosis to rapidly spread in the population febrile and irritable, and cultures of CSF obtained from the shunt yielded C. striatum. 
Corynebacterium striatum
and peritonitis associated with continuous ambulatory peritoneal dialysis. Another report describes endocarditis in a patient with a SIR-We read with interest the report by Weiss et al. [1] concernventriculoatrial shunt [2] . ing Corynebacterium striatum meningitis. We report three cases Person-to-person transmission of C. striatum has been docuof CSF-shunt infections due to C. striatum; all cases occurred in mented [3] . The three patients described in the present report were treated on the same ward, and the admission dates for the latter two children.
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11-14-97 17:32:01 cida UC: CID patients overlapped. Further molecular typing would be required to the recommended doses causes temporary or permanent inhibition of spermatogenesis. Animal data also indicate that suppression of determine if isolates from all three patients were indistinguishable and to exclude the possibility of nosocomial transmission. It apfertility in females may occur. Because of the mutagenic and teratogenic potential of ganciclovir, women of childbearing potential pears that the latter two patients acquired their C. striatum infections from colonized EVDs, thus emphasizing the potential role should be advised to use effective contraception during treatment. Similarly, men should be advised to practice barrier contraception of C. striatum in the development of CNS infections, particularly in individuals with prosthetic devices.
during and for at least 90 days following treatment . . .'' [3] . Severe CMV disease is a rare occurrence in immunocompetent patients; in fact, it is so rare, its natural history is uncertain. Any animals) might be a more appropriate choice [4] .
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Ganciclovir Therapy for Severe Cytomegalovirus Infection in Immunocompetent Patients
impairment as potential worrisome toxicities. Eddleston et al. [1] failed to mention one of the most worrisome potential toxicities of ganciclovir when it is administered to immunocompetent patients, i.e., the risk of permanent infertility and of Reply teratogenesis. In the manufacturer's package insert for ganciclovir, the following specific warnings regarding these two risks are included: ''Animal data indicate that administration of ganciclovir SIR-We thank Jacobson for pointing out the possible toxic effect of ganciclovir on the male and female reproductive systems. We causes inhibition of spermatogenesis and subsequent infertility. These effects were reversible at lower doses and irreversible at agree that these side effects, as with all potential side effects, should be borne in mind and discussed with the patient before higher doses. Although data in humans have not been obtained regarding this effect, it is considered probable that ganciclovir at ganciclovir is administered.
/ 9c40$$de52 11-14-97 17:32:01 cida UC: CID However, we did not ''recommend early insitution of ganinstitutions were not accounted for in the analysis; (2) the clinical study upon which the economic analyses were based was underciclovir therapy for immunocompetent patients with severe cytomegalovirus (CMV) disease,'' as stated by Jacobson. Instead, our powered with regard to outcomes that would tend to be important cost-drivers in an economic analysis; and (3) by using the institureview [1] suggested only that specific antiviral treatment be considered and emphasized the following points: (1) CMV infection tional perspective, the authors overlooked quality of life and other issues that are likely to be important to patients and physicians. in immunocompetent individuals may be severe, and in the worst cases, rapidly fatal. (2) In recent years, improved outcomes have While a complete economic analysis needs to be conducted to draw conclusions about the cost-effectiveness of the two treatment coincided with the use of specific antiviral agents. This finding suggests that such drugs may be valuable for severely ill patients.
approaches, the three methodological limitations of the current analysis bias the results in favor of treatment with ampicillin/ (3) Fortunately, severe manifestations are very rare complications of CMV infection. It is therefore unlikely that high-quality clinical sulbactam, making it difficult to draw meaningful conclusions from the economic data presented by McKinnon et al. [1] . trials will be performed to assess the efficacy and toxicity of specific antiviral drugs in patients with these manifestations. In the With respect to inadequate accounting of institutional cost, the authors used an average hospital per diem for the economic analyabsence of such trials, we are forced to make use of the best data available, and it is this data that we have presented in our paper.
sis and failed to account for differences in institutional costs that occur as a result of days in an intensive care unit, procedures, and The expected benefit of any treatment must be balanced against potential side effects. Severe CMV infection may prove fatal. We surgeries. Although McKinnon et al. [1] observed a shorter mean ({ SD) length of stay when ampicillin/sulbactam, rather than imitherefore believe that early administration of specific antiviral agents must be considered for patients with this CMV disease as penem/cilastatin, was used (i.e., 13 { 6.5 days vs. 15 { 8.6 days), the shorter length of stay may have resulted from the fact that soon as the severe nature of the infection is apparent. Although the possibility of future reproductive difficulties should be borne more early surgical amputations were performed in the ampicillin/ sulbactam group. Amputation was undertaken before the day-5 in mind before the decision to give ganciclovir is made, this decision must be balanced against the possibility of immediate benefit assessment for 16 (48%) of the 33 patients treated with ampicillin/ sulbactam and for six (21%) of the 28 patients treated with imito a patient with life-threatening disease.
We are happy that Jacobson's analysis of the presented data penem/cilastatin who required the procedure. The increased rate of early surgical amputation among the patients treated with ampiagrees with our own. We also agree that recommendations for treatment of CMV infections should be based on the results of cillin/sulbactam may partly reflect poor response to the study medication. Indeed, clinical improvement due to study medication behigh-quality, randomized clinical trials. Unfortunately, no such data are available or are likely to become available in the near fore amputation was noted for 12 (36%) of 33 patients treated with ampicillin/sulbactam vs. 17 (61%) of 28 patients treated with future. Instead, we must make the best use of the data that are available to us, even if they are based only on 34 case reports.
imipenem/cilastatin (P Å .10). Across the total population, 69% of the patients treated with ampicillin/sulbactam required amputation, and three of these pa-M. Eddleston imipenem/cilastatin. The study of clinical end points was underpowered. As pointed out above, treatment with imipenem/cilastatin resulted in a 16%
Antibiotic Therapy for Foot Infections in Diabetics
reduction in the amputation rate over that observed after treatment with ampicillin/sulbactam. While the study from which these re-SIR-McKinnon et al. [1] recently concluded that ampicillin/ sults were drawn was underpowered for detecting a statistical sigsulbactam was more cost-effective than imipenem/cilastatin for nificance of this important end point, the economic and qualitythe treatment of limb-threatening foot infections in diabetic paof-life implications of the results can be substantial. The study by tients; this conclusion was based on a retrospective analysis of a Grayson et al. [2] generated an important hypothesis that treatment clinical trial that was not designed to assess economic end points with imipenem/cilastatin, rather than ampicillin/sulbactam, may [2] . A number of methodological limitations of the study led us obviate the need for amputation. to question the authors' conclusions. We have three primary critiIs the perspective of the analysis correct? Society, and most important, patients, may well accept a marginal increase in the cisms: (1) dure as opposed to an amputation is not supported by data. In a review of the local representative costs, we found that digital amputation costs less than one-third as much as a vascular reconReply structive procedure, a finding corroborated by other investigators [2] . Regardless of the relative costs, these specific procedures were SIR-We appreciate the interest that Hu et al. have shown in performed for disease-based rather than drug-based reasons. our study, and we welcome the opportunity to respond to their
We certainly hold the view that quality of life is important. In methodological concerns. We accept the criticism of our use of fact, the corresponding author (J.A.P.) has attempted on numerous mean hospital per diem to model hospitalization costs but disagree occasions to add a health-related quality-of-life (HRQOL) compowith the assertion of bias. The allegation that the shorter length nent to clinical and economic studies of investigational antibiotics. of stay for the patients treated with ampicillin/sulbactam vs. those Without exception, the pharmaceutical industry has failed to suptreated with imipenem/cilastatin may have been the result of early port this attempt. The reasoning has varied surrounding the theme amputations in the ampicillin/sulbactam group and that this reflects that, for patients with acute diseases, quality of life will not drive poor response is speculation. In fact, antibiotic failure did not short-term decisions. Perhaps Hu et al. have the means to support result in any amputations. As stated in the original manuscript, such a study, and we encourage them to do so. We do not agree foot-sparing amputation reflects an aggressive approach to the that a HRQOL assessment would change the results to favor treattreatment of osteomyelitis [1] . ment with imipenem/cilastatin. As there were more serious side The first criticism of Hu et al. selectively points out several raw effects in the imipenem/cilastatin group that led to increased duranumber differences that purport to favor treatment with ampicillin/ tion of hospitalization, we would not expect to find improved sulbactam, while ignoring other differences, such as the incidence of quality of life among the patients treated with imipenem/cilastatin. osteomyelitis, which occurred in 68% of the patients treated with Finally, as hospital-based practitioners, we would not term a ampicillin/sulbactam vs. 56% of the patients treated with imipenem/ $3,000-per-patient difference a marginal increase. cilastatin. In fact, the comparisons mentioned in the first criticism are not statistically different and should not be interpreted as such. Receiving Antimycobacterial Treatment evaluations, there was no recurrence of mycobacterial infection, and after 12 months, the antituberculous treatment was discon-SIR-With the onset of the AIDS pandemic and the emergence tinued altogether. of a broad range of diseases in immunocompromised patients, Recent reports demonstrate the potential for and the importance there is renewed interest in mycobacterial diseases. In particular, of cutaneous mycobacterial involvement [1] [2] [3] [4] [5] . Disseminated skin various manifestations of the new aspects of typical mycobacterial lesions that appear during acute infection in AIDS patients have infections as well as novel pathologies due to atypical mycobacbeen attributed to M. tuberculosis [5] . Moreover, atypical mycoteria previously considered nonpathogenic have been recently rebacteria generally considered nonpathogenic (e.g., M. vaccae) have ported [1] [2] [3] [4] [5] . In 1996, two interesting papers published in Clinical been implicated in the etiology of cutaneous diseases in immunoInfectious Diseases underscored cutaneous involvement of mycocompromised patients [4] . M. gordonae infection is unusual among bacterial infections, either by Mycobacterium vaccae [4] or by HIV-negative individuals, and antituberculous drugs are rarely Mycobacterium tuberculosis [5] . Mycobacterium gordonae, usuused, even in instances in which the disease has localized to various ally considered a nonpathogenic commensal, has been recognized organs [1, 2] . Recently, M. gordonae was isolated from sputum as a pathogen in immunocompromised patients [1, 2] . Herein we and bone marrow specimens in AIDS patients [2, 3] . In the present report the case of an HIV-infected patient who developed a cutareport, we describe what is, to our knowledge, the first case of neous infection due to M. gordonae while she was being treated cutaneous disease due to M. gordonae in an HIV-infected patient, with antimycobacterial agents.
emphasizing the need to consider atypical mycobacteria as poten-A 29-year-old, HIV-infected, previously drug-addicted woman tial pathogens in immunocompromised patients. who had remained healthy until October 1994 presented to our Because of the previous diagnosis of pulmonary tuberculosis, outpatient department with fever and cough productive of sputum.
in this patient our attention was initially directed toward a possible At the time of these symptoms, her CD4 / cell count was 7/mL, recurrence of tuberculous infection with cutaneous involvement; and she had been receiving primary prophylaxis for Pneumocystis we did not immediately consider the possibility of a new, different carinii infection with trimethoprim-sulfamethoxazole; she refused mycobacterial infection. Our experience with this case has illumitreatment with antiretroviral drugs. A chest radiograph showed a nated the need for an efficient and accurate method for the diagnoperihilar lesion of the left upper lobe. A bronchoaveolar lavage sis of mycobacterial infections in immunocompromised patients, fluid specimen was obtained, and a culture of this specimen was given that these patients may be infected by atypical and unusual positive for M. tuberculosis. Therefore, a regimen of isoniazid, mycobacteria usually considered nonpathogenic. PCR has proven rifampin, pyrazinamide, and ethambutol was instituted.
useful as a diagnostic tool for the exclusion of tuberculous relapse, During this therapy, her clinical condition improved slightly, allowing consideration of the possibility of a nontuberculous infecuntil December 1994, when pyrazinamide therapy was discontion. Once again, the importance of developing sensitive PCRs tinued because of gastric intolerance. In January 1995, because of that could differentiate rapidly between several mycobacterial speher poor clinical picture and because a chest radiograph showed cies has been demonstrated. The need for diagnostic specificity is that her condition was worsening, her antituberculous therapy was underscored by the therapeutic choices that must be made in the changed to isoniazid, rifampin, ethambutol, and ciprofloxacin. In presence of infections caused by various species of mycobacteria. September 1995, the therapy was suspended for 15 days because Even for our patient, the therapeutic regimen appeared inadequate, of the sudden onset of jaundice. Subsequently, upon normalization and thus a change in therapy, driven by a specific diagnosis of M. gordonae infection, was indicated. of liver function, rifampin and ethambutol therapy was discon-/ 9c40$$de52
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In conclusion, the present report demonstrates the importance accuracy may diminish considerably in the absence of additional tests (e.g., coagulase production or novobiocin resistance) [1, 2, of considering the possibility of cutaneous lesions due to unusual mycobacteria in HIV-infected patients and the need for sensitive 5]. Our institute often receives Staphylococcus strains that have been isolated in clinical and veterinary diagnostic laboratories in and specific diagnostic assays.
Italy and tentatively identified by use of rapid commercial systems; our facility confirms the identification by use of extensive phenoStefano Rusconi, Andrea Gori, Luca Vago, Giulia Marchetti, typic and molecular characterization. In our experience, misidentiand Fabio Franzetti fications are common with the use of these commercial systems, which they describe the first reported case of primary septic arthri- vobiocin resistant. In addition, these strains are phosphatase and The isolates were subjected to antimicrobial susceptibility testurease positive and produce acid aerobically from mannitol, suing by use of the broth microdilution method according to the crose, trehalose, mannose, xylose, fructose, arabinose, maltose, procedures outlined by the National Committee for Clinical Laboand lactose. These strains do not, however, metabolize ribose and ratory Standards. Although misidentification of CONS may be xylitol. frequent in the microbiological laboratory and other species of Several different methods may be used for the detection of CONS may produce biochemical reactions similar to those of infection due to CONS; these methods include biotyping, antibiotic S. cohnii and S. xylosus, as noted by Varaldo and Biavasco, there susceptibility pattern analysis, serological typing, phage typing, are some key characteristics, determinable by simple laboratory slime-production detection, protein-profile analysis, immunoblot techniques, that are sufficiently discriminatory and, thus, adequate fingerprinting, and DNA typing; however, application of these for the differentiation of these species. The more common distinmethods is particularly suited to the epidemiological study of guishing biochemical characteristics of S. cohnii, Staphylococcus CONS isolates. In fact, prompt distinction between different Staphepidermidis, and Staphylococcus capitis and conventional bioylococcus species by use of phenotypic-trait study and molecular chemical tests for identification of S. xylosus and Staphylococcus analysis aids in the determination of the epidemiological patterns aureus are presented in tables 1 and 2. A coagulase-negative Staphof these organisms. Recently, we reported that S. cohnii is an ylococcus isolate can be identified presumptively as ''S. cohnii'' uncommon pathogen in our hospital, occurring at low frequency if the Voges-Proskauer test of acetoin production from glucose, a but associated with high morbidity [3] [4] .
We believe that microbiological laboratories should be encouraged to identify infection caused by CONS by use of appropriate in all 11 cases. Ten patients presented with symptoms and signs case report about antiphospholipid syndrome related to acute cytoof chronic meningitis. The remaining patient had no signs of menmegalovirus (CMV) infection in an immunocompetent host [1] .
ingeal involvement and presented with pyrexia of unknown origin. Prieto et al. showed strong evidence that hepatitis C virus (HCV)
Six of 11 patients were immunocompromised because of underlyinfection is associated with the presence of antiphospholipid autoing illness, but none of the patients had AIDS. antibodies and a high incidence of thrombotic disorders in this Because of the known specificity of cryptococcal antigen assay, group of patients [2] . Therefore, there is growing evidence that antifungal therapy was instituted for all of the patients, eight of antiphospholipid autoantibodies related to viral infections could whom responded well. The other three patients died of their illbe pathogenic and are not only an epiphenomenon. However, there nesses. One patient was autopsied, and yeast cells with capsules is some evidence that enveloped virus could have some procoaguwere identified in meningeal tissue. The cross-reaction of Trilant activities. For example, it has been shown that the CMV chosporon antigen and Cryptococcus antigen is known [3] . Howsurface contains the necessary procoagulant phospholipid for coagever, the rarity of disseminated trichosporon infection in northern ulation enzyme complex assembly [3] .
India led us to believe that all of these patients had cryptococcosis; In addition, patients with cirrhosis secondary to HCV infection this could even be confirmed by autopsy in one case. Therefore, and thrombosis could have other procoagulant alterations that excryptococcal antigen assay should be included as part of the routine plain the thrombotic problems [4] . In this sense, the hypothesis of diagnostic protocol for all patients with chronic meningitis. two cases of Mycobacterium avium complex (MAC) meningitis TTP is a disorder that can be classified among thrombotic microand the article by Smith et al. [2] reporting a fatal case of Mycobacangiopathies along with hemolytic uremic syndrome (HUS). In terium fortuitum meningitis in a patient with AIDS. We recently TTP, microangiopathic hemolytic anemia is associated with schispublished a comprehensive review of CNS infections due to all tocytosis, thrombocytopenia, and neurological dysfunction (often species of nontuberculous mycobacteria that included meningitis, with fever and renal involvement) [3] . TTP has been described as encephalitis, and brain or spinal cord abscesses [3] . We believe occurring in the setting of viral infections, principally HIV and, that each of us was responding to an apparent increase in these more rarely, human T-lymphotropic virus type 1 [4] . From a pathodiseases in recent years. physiologic standpoint, TTP results from damage to vascular endoWe identified 56 cases of MAC disease of the CNS (48 of thelial cells and platelet aggregation, leading to the formation of the patients had AIDS). Most of these patients had meningitis or arteriolar microthrombi in different organs, predominately the kidmeningoencephalitis. Two of the patients without AIDS had brain ney and brain [5] . CMV is known to have an affinity for the abscesses, and on the basis of postmortem or brain biopsy examinavascular endothelium [6] , and endothelial-cell lesions linked to tions, nine were described as having encephalitis without evident viral replication might thus give rise to TTP. meningeal disease. Six of nine patients with Mycobacterium kanThe prognosis of TTP in the absence of treatment is poor, with sasii disease of the CNS had AIDS. Two of these patients had death often occurring in days or weeks [5] . Treatment generally abscesses without evident meningitis. Seven cases of M. fortuitum consists of corticosteroids and plasma transfusions [7] . Such man-CNS disease were identified, including two cases (one case of agement led to our patient's rapid recovery.
ventriculitis and one case of brain abscess) not included in the The present case of TTP and another case involving HUS [2] review by Smith et al. [2] . Five of these patients had meningitis, probably justify systematic searching for an underlying primary three had abscesses of the CNS, and one each had subdural empy-CMV infection in patients with thrombotic microangiopathies. genavense, and Mycobacterium terrae were identified [3] . Thus, with the reports of CNS disease due to MAC [1] and M. fortuitum [2] , there have been a total of at least 79 reported
